miR-216 是人类癌症的一个关键调节剂和潜在标记物
Mozhgan Mondeali1, Fatemeh Mozaffari2, Pooran Ghiasizadeh3
1Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Advanced biomedical research
|June 16, 2025
概括
微RNA-216 (miR-216) 在各种癌症中显示出作为瘤基因或瘤抑制剂的双重作用. 它的改变表达表明,它有可能成为早期癌症检测和进展监测的预后生物标志物.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 微RNAs调节基因表达和细胞通路,作为潜在的癌症生物标志物.
- 微RNA-216 (miR-216) 涉及各种癌症,作为瘤基因或瘤抑制剂.
- 了解miR-216的分子基础和临床相关性对于癌症管理至关重要.
研究的目的:
- 对癌症中微RNA-216 (miR-216) 的当前发现进行审查和综合.
- 阐明miR-216的分子机制和临床意义.
- 评估miR-216作为预后生物标记物的潜力.
主要方法:
- 对研究研究miR-216表达和功能在各种癌症类型的文献综述.
- 分析了miR-216作为瘤基因或瘤抑制剂的作用.
- 关于miR-216与瘤发育,进展和转移相关的数据汇编.
主要成果:
- 在许多癌症中观察到miR-216的改变表达 (上调或下调).
- 具体的癌症包括食道癌,乳腺癌,结肠直肠癌,胃癌,胰腺癌,宫癌,质瘤,前列腺癌和急性髓性白血病.
- 根据癌症类型,miR-216可以作为瘤基因或瘤抑制剂.
结论:
- 微RNA-216 (miR-216) 在癌症中表现出上下文依赖的作用,作为瘤基因或瘤抑制剂.
- 在各种恶性瘤中,miR-216的失调突显了它在瘤发生中的重要性.
- miR-216作为癌症早期检测,进展和转移预测的预后生物标志物具有前景.
相关概念视频
Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K


